This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

Commit To Buy Zumiez At $12.50, Earn 10.8% Annualized Using Options

Investors eyeing a purchase of Zumiez Inc stock, but tentative about paying the going market price of $16.65/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $12.50 strike, which has a bid at the time of this writing of 75 cents.

Commit To Purchase Merrimack Pharmaceuticals At $6, Earn 15.8% Annualized Using Options

Investors eyeing a purchase of Merrimack Pharmaceuticals Inc. stock, but cautious about paying the going market price of $7.30/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Commit To Buy El Pollo Loco Holdings At $8, Earn 8.8% Using Options

Investors eyeing a purchase of El Pollo Loco Holdings Inc stock, but tentative about paying the going market price of $13.20/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2018 put at the $8 strike, which has a bid at the time of this writing of 70 cents.

Commit To Buy Foundation Medicine At $12.50, Earn 19.4% Annualized Using Options

Investors eyeing a purchase of Foundation Medicine Inc shares, but tentative about paying the going market price of $16.05/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $12.50 strike, which has a bid at the time of this writing of $1.35.

Commit To Buy Epizyme At $7.50, Earn 20.4% Annualized Using Options

Investors eyeing a purchase of Epizyme Inc. shares, but cautious about paying the going market price of $10.84/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Commit To Purchase Encore Capital Group At $20, Earn 9.1% Annualized Using Options

Investors considering a purchase of Encore Capital Group Inc stock, but cautious about paying the going market price of $28.23/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $20 strike, which has a bid at the time of this writing of $1.15.

Commit To Purchase Concert Pharmaceuticals At $12.50, Earn 26.7% Annualized Using Options

Investors considering a purchase of Concert Pharmaceuticals Inc stock, but tentative about paying the going market price of $13.96/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $12.50 strike, which has a bid at the time of this writing of $1.60.

Commit To Buy Accelerate Diagnostics At $10, Earn 19.8% Annualized Using Options

Investors eyeing a purchase of Accelerate Diagnostics Inc shares, but tentative about paying the going market price of $12.57/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $10 strike, which has a bid at the time of this writing of $1.10.

Commit To Purchase ANI Pharmaceuticals At $35, Earn 12.4% Annualized Using Options

Investors considering a purchase of ANI Pharmaceuticals, Inc. stock, but tentative about paying the going market price of $47.54/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Strategy To YieldBoost BRSS From 0.5% To 10.3% Using Options

Shareholders of Global Brass & Copper Holdings Inc looking to boost their income beyond the stock's 0.5% annualized dividend yield can sell the October covered call at the $30 strike and collect the premium based on the $1.30 bid, which annualizes to an additional 9.8% rate of return against the current stock price (at Stock Options Channel we call this the YieldBoost), for a total of 10.3% annualized rate in the scenario where the stock is not called away. Any upside above $30 would be lost if the stock rises there and is called away, but BRSS shares would have to climb 8.7% from current levels for that to occur, meaning that in the scenario where the stock is called, the shareholder has earned a 13.4% return from this trading level, in addition to any dividends collected before the stock was called.

Page 1 of 485
< Previous
Top Rated Stocks Top Rated Funds Top Rated ETFs